The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with ...

WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as ...

(Reuters) -The U.S. Food and Drug Administration on Tuesday announced that it will issue a new priority review voucher to ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

The Food & Drug Administration (FDA) is warning consumers and businesses about Emek-brand pistachio cream, imported from ...

Garadacimab-gxii is the first and only treatment that targets factor XIIa (FXIIa) for the prophylactic prevention of reditary ...

Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...

KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...